This page is optimized for AI. For the human-readable: Phialogics AG

Phialogics AG

Organization Metadata

Organization Description

We are a preclinical company developing cell-type-specific immune checkpoint activators to prevent multi-organ failure in autoimmune diseases. We engineer next generation biologics that rebalance the immune response in acute and chronic inflammation.